{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:48:54Z","timestamp":1792180134140,"version":"4.4.0"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010790","name":"Erasmus Plus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["BRC-1215-20014"],"award-info":[{"award-number":["BRC-1215-20014"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019544","name":"Cambridge Centre for Parkinson-Plus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000735","name":"University of Cambridge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.arr.2022.101771","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T21:40:53Z","timestamp":1667252453000},"page":"101771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["From protein biomarkers to proteomics in dementia with Lewy Bodies"],"prefix":"10.1016","volume":"83","author":[{"given":"Augoustos","family":"Tsamourgelis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Swann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Chouliaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.arr.2022.101771_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3233\/JAD-2006-9309","article-title":"Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders","volume":"9","author":"Abdi","year":"2006","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"2","key":"10.1016\/j.arr.2022.101771_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3233\/JAD-2011-110482","article-title":"CSF tau, A\u03b242, and MHPG differentiate dementia with lewy bodies from alzheimer\u2019s disease","volume":"27","author":"Aerts","year":"2011","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"11","key":"10.1016\/j.arr.2022.101771_bib3","doi-asserted-by":"crossref","first-page":"1206 LP","DOI":"10.1136\/jnnp-2021-326603","article-title":"Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias","volume":"92","author":"Alcolea","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrg3356","article-title":"Next-generation proteomics: towards an integrative view of proteome dynamics","volume":"14","author":"Altelaar","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.arr.2022.101771_bib5","series-title":"Proteome Bioinformatics","first-page":"31","article-title":"Label-based and label-free strategies for protein quantitation","author":"Anand","year":"2017"},{"issue":"2","key":"10.1016\/j.arr.2022.101771_bib6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/chromsci\/bmw167","article-title":"Proteomics: technologies and their applications","volume":"55","author":"Aslam","year":"2017","journal-title":"J. Chromatogr. Sci."},{"issue":"3","key":"10.1016\/j.arr.2022.101771_bib7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bpa.12370","article-title":"Alpha-synuclein as a biomarker for Parkinson\u2019s disease","volume":"26","author":"Atik","year":"2016","journal-title":"Brain Pathol."},{"key":"10.1016\/j.arr.2022.101771_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/282574","article-title":"Electrospray ionization mass spectrometry: a technique to access the information beyond the molecular weight of the analyte","volume":"2012","author":"Banerjee","year":"2012","journal-title":"Int. J. Anal. Chem."},{"issue":"2","key":"10.1016\/j.arr.2022.101771_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.nbd.2005.11.005","article-title":"Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies","volume":"22","author":"Barrachina","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.arr.2022.101771_bib10","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3233\/JAD-150962","article-title":"Differential mass spectrometry profiles of tau protein in the cerebrospinal fluid of patients with Alzheimer\u2019s disease, progressive supranuclear palsy, and dementia with lewy bodies","volume":"51","author":"Barth\u00e9lemy","year":"2016","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3233\/JPD-150680","article-title":"Prevalence of submandibular gland synucleinopathy in parkinson\u2019s disease, dementia with lewy bodies and other lewy body disorders","volume":"6","author":"Beach","year":"2016","journal-title":"J. Parkinson\u2019s Dis."},{"issue":"6","key":"10.1016\/j.arr.2022.101771_bib12","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","article-title":"The function of \u03b1-synuclein","volume":"79","author":"Bendor","year":"2013","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.arr.2022.101771_bib13","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/brain\/awx352","article-title":"Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach","volume":"141","author":"Bereczki","year":"2018","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.arr.2022.101771_bib14","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jalz.2016.04.005","article-title":"Synaptic proteins predict cognitive decline in Alzheimer\u2019s disease and Lewy body dementia","volume":"12","author":"Bereczki","year":"2016","journal-title":"Alzheimer\u2019s Dement."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.arr.2022.101771_bib16","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1042\/BST20120122","article-title":"The importance of Wnt signalling for neurodegeneration in Parkinson\u2019s disease","volume":"40","author":"Berwick","year":"2012","journal-title":"Biochem. Soc. Trans."},{"issue":"2","key":"10.1016\/j.arr.2022.101771_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-03441-0","article-title":"Expanding the role of proteasome homeostasis in Parkinson\u2019s disease: beyond protein breakdown","volume":"12","author":"Bi","year":"2021","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.arr.2022.101771_bib18","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/brain\/awl063","article-title":"CSF amyloid-\u03b2-peptides in Alzheimer\u2019s disease, dementia with Lewy bodies and Parkinson\u2019s disease dementia","volume":"129","author":"Bibl","year":"2006","journal-title":"Brain"},{"issue":"6702","key":"10.1016\/j.arr.2022.101771_bib19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/bmj.299.6702.783","article-title":"High performance liquid chromatography: principles and clinical applications","volume":"299","author":"Bird","year":"1989","journal-title":"Br. Med. J."},{"key":"10.1016\/j.arr.2022.101771_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parkreldis.2019.03.001","article-title":"Proteomic analysis of tear fluid reveals disease-specific patterns in patients with Parkinson\u2019s disease \u2013 a pilot study","volume":"63","author":"Boerger","year":"2019","journal-title":"Park. Relat. Disord."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/mas.21520","article-title":"Time-of-flight mass spectrometry: introduction to the basics","volume":"36","author":"Boesl","year":"2017","journal-title":"Mass Spectrom. Rev."},{"issue":"4","key":"10.1016\/j.arr.2022.101771_bib22","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3233\/JAD-150731","article-title":"Diagnostic value of cerebrospinal fluid biomarkers (phospho-Tau181, total-Tau, A\u03b242, and A\u03b240) in prodromal stage of Alzheimer\u2019s disease and dementia with lewy bodies","volume":"51","author":"Bousiges","year":"2016","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"7","key":"10.1016\/j.arr.2022.101771_bib23","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1021\/acs.chemrev.9b00440","article-title":"Ultraviolet photodissociation mass spectrometry for analysis of biological molecules","volume":"120","author":"Brodbelt","year":"2020","journal-title":"Chem. Rev."},{"issue":"6","key":"10.1016\/j.arr.2022.101771_bib24","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/jnc.13216","article-title":"Dickkopf-related protein 3 is a potential A\u03b2-associated protein in Alzheimer\u2019s Disease","volume":"134","author":"Bruggink","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2022.101771_bib25","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0084-3970(08)70284-6","article-title":"Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study","volume":"2006","author":"Buckley","year":"2006","journal-title":"Yearb. Psychiatry Appl. Ment. Health"},{"issue":"21","key":"10.1016\/j.arr.2022.101771_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111340","article-title":"Tackling the biological meaning of the human olfactory bulb dyshomeostatic proteome across neurological disorders: an integrative bioinformatic approach","volume":"22","author":"Cartas-Cejudo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2022.101771_bib27","article-title":"Do post-translational modifications influence protein aggregation in neurodegenerative diseases","author":"Carter","year":"2020","journal-title":"Brain Sci."},{"issue":"1\u20132","key":"10.1016\/j.arr.2022.101771_bib28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jim.2012.02.011","article-title":"Single molecule enzyme-linked immunosorbent assays: theoretical considerations","volume":"378","author":"Chang","year":"2012","journal-title":"J. Immunol. Methods"},{"issue":"8","key":"10.1016\/j.arr.2022.101771_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082873","article-title":"Bioinformatics methods for mass spectrometry-based proteomics data analysis","volume":"21","author":"Chen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2022.101771_bib30","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3389\/fnins.2018.00163","article-title":"The association of tau with mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"12","author":"Cheng","year":"2018","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib31","first-page":"1","article-title":"Differential role of CSF fatty acid binding protein 3, \u03b1-synuclein, and Alzheimer\u2019s disease core biomarkers in Lewy body disorders and Alzheimer\u2019s dementia","volume":"9","author":"Chiasserini","year":"2017","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"4","key":"10.1016\/j.arr.2022.101771_bib32","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4155\/bio.13.348","article-title":"Stable isotope-labeling studies in metabolomics: new insights into structure and dynamics of metabolic networks","volume":"6","author":"Chokkathukalam","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.arr.2022.101771_bib33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.csbj.2018.08.003","article-title":"Clinical mass spectrometry in the bioinformatics era: a Hitchhiker\u2019s guide","volume":"16","author":"Chong","year":"2018","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"6","key":"10.1016\/j.arr.2022.101771_bib34","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/jnnp-2021-327788","article-title":"Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer\u2019s disease, frontotemporal dementia and progressive supranuclear palsy","volume":"93","author":"Chouliaras","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.arr.2022.101771_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10735-006-9049-2","article-title":"Tissue microarrays as a platform for proteomic investigation","volume":"38","author":"Chung","year":"2007","journal-title":"J. Mol. Histol."},{"issue":"3","key":"10.1016\/j.arr.2022.101771_bib36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1128\/CMR.00072-12","article-title":"Matrix-Assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology","volume":"26","author":"Clark","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"issue":"12","key":"10.1016\/j.arr.2022.101771_bib37","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1093\/brain\/awx275","article-title":"Synaptic phosphorylated \u03b1-synuclein in dementia with Lewy bodies","volume":"140","author":"Colom-Cadena","year":"2017","journal-title":"Brain"},{"issue":"03","key":"10.1016\/j.arr.2022.101771_bib38","article-title":"Fundamentals of contemporary mass spectrometry","volume":"Vol. 45","author":"Dass","year":"2007","journal-title":"Choice Rev."},{"issue":"SUPPL. 1","key":"10.1016\/j.arr.2022.101771_bib39","first-page":"1","article-title":"The role of parkin in familial and sporadic Parkinson\u2019s disease","volume":"25","author":"Dawson","year":"2010","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-66090-x","article-title":"Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders","volume":"10","author":"Delaby","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib41","first-page":"1","article-title":"The A\u03b21\u201342\/A\u03b21\u201340 ratio in CSF is more strongly associated to tau markers and clinical progression than A\u03b21\u201342 alone","volume":"14","author":"Delaby","year":"2022","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"15","key":"10.1016\/j.arr.2022.101771_bib42","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1093\/bioinformatics\/bts327","article-title":"MobiDB: a comprehensive database of intrinsic protein disorder annotations","volume":"28","author":"Di Domenico","year":"2012","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.arr.2022.101771_bib43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3233\/JAD-121810","article-title":"Low-abundant cerebrospinal fluid proteome alterations in dementia with Lewy bodies","volume":"34","author":"Dieks","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"11","key":"10.1016\/j.arr.2022.101771_bib44","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1007\/s13361-019-02288-2","article-title":"Ion mobility spectrometry: fundamental concepts, instrumentation, applications, and the road ahead","volume":"30","author":"Dodds","year":"2019","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"15","key":"10.1016\/j.arr.2022.101771_bib45","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1212\/WNL.0000000000000316","article-title":"Skin nerve a-synuclein deposits A biomarker for idiopathic Parkinson disease","volume":"82","author":"Donadio","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.arr.2022.101771_bib46","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1212\/WNL.0000000000004146","article-title":"A new potential biomarker for dementia with Lewy bodies","volume":"89","author":"Donadio","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2022.101771_bib47","first-page":"2833","article-title":"Proteomics and bioinformatics approaches for the identification of plasma biomarkers to detect Parkinson\u2019s disease","author":"Dong","year":"2019","journal-title":"Exp. Ther. Med."},{"issue":"11","key":"10.1016\/j.arr.2022.101771_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17111778","article-title":"iTRAQ-based quantitative proteomic analysis of the potentiated and dormant antler stem cells","volume":"17","author":"Dong","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"June","key":"10.1016\/j.arr.2022.101771_bib49","first-page":"1","article-title":"Serum and fecal markers of intestinal inflammation and intestinal barrier permeability are elevated in Parkinson\u2019s disease","volume":"15","author":"Dumitrescu","year":"2021","journal-title":"Front. Neurosci."},{"issue":"12","key":"10.1016\/j.arr.2022.101771_bib50","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2022.101771_bib51","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-puente, P., Mateos, J., & Blanco, F.J. (2014). Chapter 2 LC-MALDI-TOF \/ TOF for Shotgun Proteomics. 1156(June 2016), 27\u201338. https:\/\/doi.org\/10.1007\/978\u20131-4939\u20130685-7.","DOI":"10.1007\/978-1-4939-0685-7_2"},{"key":"10.1016\/j.arr.2022.101771_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cr.2017.09.001","article-title":"Genomic and molecular control of cell type and cell type conversions","volume":"6","author":"Fu","year":"2017","journal-title":"Cell Regen."},{"issue":"2","key":"10.1016\/j.arr.2022.101771_bib53","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"\u0391-synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-49668-y","article-title":"Comprehensive proteomic profiling of plasma-derived Extracellular Vesicles from dementia with Lewy Bodies patients","volume":"9","author":"G\u00e1mez-Valero","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.arr.2022.101771_bib55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4172\/jpb.1000434","article-title":"Proteomics analysis for therapeutic options of neurodegeneration: a review","volume":"10","author":"Ganash","year":"2017","journal-title":"J. Proteom. Bioinforma."},{"key":"10.1016\/j.arr.2022.101771_bib56","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative damage linked to neurodegeneration by selective a-synuclein nitration in synucleinopathy lesions","volume":"290","author":"Giasson","year":"2000","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.arr.2022.101771_bib57","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/archneur.60.9.1218","article-title":"Cerebrospinal fluid markers in dementia with Lewy bodies compared with Alzheimer disease","volume":"60","author":"G\u00f3mez-Tortosa","year":"2003","journal-title":"Arch. Neurol."},{"issue":"8","key":"10.1016\/j.arr.2022.101771_bib58","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/mds.25048","article-title":"Brain amyloid and cognition in Lewy body diseases","volume":"27","author":"Gomperts","year":"2012","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.arr.2022.101771_bib59","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","article-title":"Tau positron emission tomographic imaging in the lewy body diseases","volume":"73","author":"Gomperts","year":"2016","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib60","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jamaneurol.2021.4222","article-title":"Association of Plasma p-tau181 and p-tau231 concentrations with cognitive decline in patients with probable dementia with lewy bodies","volume":"79","author":"Gonzalez","year":"2022","journal-title":"JAMA Neurol."},{"issue":"18","key":"10.1016\/j.arr.2022.101771_bib61","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1002\/pmic.200800495","article-title":"High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry","volume":"8","author":"Groseclose","year":"2008","journal-title":"Proteomics"},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib62","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(17)30400-3","article-title":"Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study","volume":"17","author":"Guerreiro","year":"2018","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib63","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archpsyc.61.1.95","article-title":"Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study","volume":"61","author":"Hampel","year":"2004","journal-title":"Archives of general psychiatry"},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-021-01242-2","article-title":"Disease-, region- and cell type specific diversity of \u03b1-synuclein carboxy terminal truncations in synucleinopathies","volume":"9","author":"Hass","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"issue":"7","key":"10.1016\/j.arr.2022.101771_bib65","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1021\/acschemneuro.1c00028","article-title":"Effects of \u03b1-synuclein-associated post-translational modifications in Parkinson\u2019s disease","volume":"12","author":"He","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-015-0059-y","article-title":"Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay","volume":"10","author":"Heywood","year":"2015","journal-title":"Mol. Neurodegener."},{"issue":"18","key":"10.1016\/j.arr.2022.101771_bib67","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1002\/pmic.201270086","article-title":"New and improved proteomics technologies for understanding complex biological systems: Addressing a grand challenge in the life sciences","volume":"12","author":"Hood","year":"2012","journal-title":"Proteomics"},{"key":"10.1016\/j.arr.2022.101771_bib68","doi-asserted-by":"crossref","unstructured":"Huxford, T. (2013). X-Ray Crystallography. Brenner\u2019s Encyclopedia of Genetics: Second Edition, 366\u2013368. https:\/\/doi.org\/10.1016\/B978\u20130-12\u2013374984-0.01657\u20130.","DOI":"10.1016\/B978-0-12-374984-0.01657-0"},{"issue":"10","key":"10.1016\/j.arr.2022.101771_bib69","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/NEN.0b013e318186de48","article-title":"Lewy body pathology involves cutaneous nerves","volume":"67","author":"Ikemura","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"04","key":"10.1016\/j.arr.2022.101771_bib70","article-title":"The contribution of tau, amyloid-beta and alpha-synuclein pathology to dementia in lewy body disorders","volume":"08","author":"Irwin","year":"2018","journal-title":"J. Alzheimer\u2019s Dis. Park."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib71","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","article-title":"Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis","volume":"16","author":"Irwin","year":"2017","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.arr.2022.101771_bib72","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0304-3940(02)00418-4","article-title":"Immunohistochemical study of synphilin-1 in brains of patients with dementia with Lewy bodies - Synphilin-1 is non-specifically implicated in the formation of different neuronal cytoskeletal inclusions","volume":"326","author":"Iseki","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2022.101771_bib73","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/0256-4947.51806","article-title":"mini-review tiSSue MicroArrAy","volume":"29","author":"Jawhar","year":"2009","journal-title":"Ann. Saudi Med."},{"key":"10.1016\/j.arr.2022.101771_bib74","first-page":"1","article-title":"Reversed-phase high performance liquid chromatography of proteins","volume":"2010","author":"Josic","year":"2010","journal-title":"Curr. Protoc. Protein Sci."},{"issue":"9","key":"10.1016\/j.arr.2022.101771_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0222032","article-title":"Proteomics approach to identify serum biomarkers associated with the progression of diabetes in Korean patients with abdominal obesity","volume":"14","author":"Kim","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.arr.2022.101771_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0064649","article-title":"Altered Serum IgG Levels to \u03b1-Synuclein in Dementia with Lewy Bodies and Alzheimer\u2019s Disease","volume":"8","author":"Koehler","year":"2013","journal-title":"PLoS One"},{"issue":"29","key":"10.1016\/j.arr.2022.101771_bib77","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/bpa.12890","article-title":"RAB39B is redistributed in dementia with Lewy bodies and is sequestered within a \u03b2 plaques and Lewy bodies","volume":"31","author":"Koss","year":"2021","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib78","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00441-004-0953-z","article-title":"The role of synphilin-1 in synaptic function and protein degradation","volume":"318","author":"Kr\u00fcger","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.arr.2022.101771_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2021.747333","article-title":"Application of proteomics in cancer: recent trends and approaches for biomarkers discovery","volume":"8","author":"Kwon","year":"2021","journal-title":"Front. Med."},{"issue":"17","key":"10.1016\/j.arr.2022.101771_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21176371","article-title":"Proteomic characterization of the olfactory molecular imbalance in dementia with lewy bodies","volume":"21","author":"Lach\u00e9n-Montes","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.arr.2022.101771_bib81","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000329763","article-title":"Decreased \u03b1-synuclein serum levels in patients with lewy body dementia compared to alzheimer\u2019s disease patients and control subjects","volume":"31","author":"Laske","year":"2011","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"8","key":"10.1016\/j.arr.2022.101771_bib82","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/gerona\/63.8.879","article-title":"Elisa and multiplex technologies for cytokine","volume":"63","author":"Leng","year":"2008","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"issue":"4","key":"10.1016\/j.arr.2022.101771_bib83","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/jnc.14603","article-title":"Proteomics of neurodegenerative diseases: analysis of human post-mortem brain","volume":"151","author":"Li","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2022.101771_bib84","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-017-0226-4","article-title":"YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias","volume":"12","author":"Llorens","year":"2017","journal-title":"Mol Neurodegeneration"},{"issue":"February","key":"10.1016\/j.arr.2022.101771_bib85","first-page":"1","article-title":"SpotLight Proteomics: uncovering the hidden blood proteome improves diagnostic power of proteomics","volume":"7","author":"Lundstr\u00f6m","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2022.101771_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/database\/bar009","article-title":"UniProt knowledgebase: a hub of integrated protein data","volume":"2011","author":"Magrane","year":"2011","journal-title":"Database"},{"issue":"9","key":"10.1016\/j.arr.2022.101771_bib87","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4103\/1947-2714.100998","article-title":"Western blot: Technique, theory, and trouble shooting","volume":"4","author":"Mahmood","year":"2012","journal-title":"North Am. J. Med. Sci."},{"issue":"June","key":"10.1016\/j.arr.2022.101771_bib88","first-page":"1","article-title":"Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders","volume":"13","author":"Manzanza","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"4","key":"10.1016\/j.arr.2022.101771_bib89","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","article-title":"Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study","volume":"6","author":"McKeith","year":"2007","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib90","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2022.101771_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100138","article-title":"Trapped ion mobility spectrometry and parallel accumulation\u2013serial fragmentation in proteomics","volume":"20","author":"Meier","year":"2021","journal-title":"Mol. Cell. Proteom."},{"issue":"6","key":"10.1016\/j.arr.2022.101771_bib92","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1021\/jasms.1c00099","article-title":"Novel Strategies to Address the Challenges in Top-Down Proteomics","volume":"32","author":"Melby","year":"2021","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.arr.2022.101771_bib93","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-7268-5_1","article-title":"Two-dimensional gel electrophoresis and 2D-DIGE","volume":"1664","author":"Meleady","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.arr.2022.101771_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2022.852003","article-title":"Alpha-synuclein targeting therapeutics for Parkinson\u2019s disease and related synucleinopathies","volume":"13","author":"Menon","year":"2022","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib95","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3233\/JAD-170502","article-title":"Current approaches and clinician attitudes to the use of cerebrospinal fluid biomarkers in diagnostic evaluation of dementia in Europe","volume":"60","author":"Miller","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2022.101771_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/743193","article-title":"The HER2 receptor in breast cancer: pathophysiology, clinical use, and new advances in therapy","volume":"2012","author":"Mitri","year":"2012","journal-title":"Chemother. Res. Pract."},{"issue":"5","key":"10.1016\/j.arr.2022.101771_bib97","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000105157","article-title":"Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodies","volume":"4","author":"Mollenhauer","year":"2007","journal-title":"Neurodegener. Dis."},{"issue":"2","key":"10.1016\/j.arr.2022.101771_bib98","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.expneurol.2008.06.004","article-title":"Direct quantification of CSF \u03b1-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration","volume":"213","author":"Mollenhauer","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2022.101771_bib99","doi-asserted-by":"crossref","first-page":"7803","DOI":"10.1038\/s41598-019-44173-8","article-title":"Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer\u2019s disease","volume":"9","author":"Morenas-Rodr\u00edguez","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.arr.2022.101771_bib100","first-page":"2010","article-title":"Cerebrospinal fluid biomarkers for dementia with lewy bodies","author":"Mukaetova-Ladinska","year":"2010","journal-title":"Int. J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2022.101771_bib101","first-page":"1","article-title":"Chemical ionization mass spectrometry: theory and applications","author":"Munson","year":"2000","journal-title":"Encycl. Anal. Chem."},{"issue":"2","key":"10.1016\/j.arr.2022.101771_bib102","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/mas.21681","article-title":"Fourier transform ion cyclotron resonance mass spectrometry at the true cyclotron frequency","volume":"41","author":"Nagornov","year":"2022","journal-title":"Mass Spectrom. Rev."},{"issue":"9","key":"10.1016\/j.arr.2022.101771_bib103","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nmeth0910-681","article-title":"Mass spectrometry in high-throughput proteomics: Ready for the big time","volume":"7","author":"Nilsson","year":"2010","journal-title":"Nat. Methods"},{"issue":"5","key":"10.1016\/j.arr.2022.101771_bib104","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/14789450.2017.1319768","article-title":"Mass spectrometry-based proteomic exploration of the human immune system: focus on the inflammasome, global protein secretion, and T cells","volume":"14","author":"Nyman","year":"2017","journal-title":"Expert Rev. Proteom."},{"key":"10.1016\/j.arr.2022.101771_bib105","first-page":"270","article-title":"A proteomic signature for dementia with Lewy bodies","volume":"11","author":"O\u2019Bryant","year":"2019","journal-title":"Alzheimer\u2019s Dement. Diagn. Assess. Dis. Monit."},{"issue":"10","key":"10.1016\/j.arr.2022.101771_bib106","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1074\/mcp.M116.059915","article-title":"Alpha-, beta-, and gamma-synuclein quantification in cerebrospinal fluid by multiple reaction monitoring reveals increased concentrations in Alzheimer\u2019s and creutzfeldt-jakob disease but no alteration in synucleinopathies","volume":"15","author":"Oeckl","year":"2016","journal-title":"Mol. Cell. Proteom."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib107","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-59745-255-7_3","article-title":"Stable isotope labeling by amino acids in cell culture for quantitative proteomics","volume":"359","author":"Ong","year":"2007","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-019-0306-8","article-title":"Dementia with Lewy bodies: An update and outlook","volume":"14","author":"Outeiro","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"3","key":"10.1016\/j.arr.2022.101771_bib109","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3233\/JPD-160867","article-title":"Nilotinib effects in Parkinson\u2019s disease and dementia with lewy bodies","volume":"6","author":"Pagan","year":"2016","journal-title":"J. Parkinson\u2019s Dis."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib110","first-page":"1","article-title":"Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies","volume":"8","author":"Pagan","year":"2022","journal-title":"Alzheimer\u2019s Dement.: Transl. Res. Clin. Interv."},{"key":"10.1016\/j.arr.2022.101771_bib111","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s100720170055","article-title":"CSF phosphorylated tau is a possible marker for discriminating Alzheimer\u2019s disease from dementia with Lewy bodies E. Vanmechelen 2 @BULLET F. Hulstaert 2 for the Phospho-Tau International Study Group*","volume":"22","author":"Parnetti","year":"2001","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-27387-1","article-title":"Mapping the serum proteome to neurological diseases using whole genome sequencing","volume":"12","author":"Png","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib113","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/14789450.4.1.51","article-title":"Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices","volume":"4","author":"Poon","year":"2007","journal-title":"Expert Rev. Proteom."},{"issue":"4","key":"10.1016\/j.arr.2022.101771_bib114","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1042\/BST20210181","article-title":"Methods for the solubilisation of membrane proteins: The micelle-aneous world of membrane protein solubilisation","volume":"49","author":"Ratkeviciute","year":"2021","journal-title":"Biochem. Soc. Trans."},{"issue":"2","key":"10.1016\/j.arr.2022.101771_bib115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","article-title":"Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer\u2019s disease","volume":"14","author":"Reddy","year":"2008","journal-title":"Trends Mol. Med."},{"issue":"12","key":"10.1016\/j.arr.2022.101771_bib116","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/prca.201500150","article-title":"CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer\u2019s disease","volume":"10","author":"Remnest\u00e5l","year":"2016","journal-title":"Proteom. Clin. Appl."},{"issue":"9","key":"10.1016\/j.arr.2022.101771_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm8091377","article-title":"DJ-1 in Parkinson\u2019s disease: clinical insights and therapeutic perspectives","volume":"8","author":"Repici","year":"2019","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib118","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1021\/acs.analchem.7b04810","article-title":"The role of electron transfer dissociation in modern proteomics","volume":"90","author":"Riley","year":"2018","journal-title":"Anal. Chem."},{"issue":"4","key":"10.1016\/j.arr.2022.101771_bib119","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/jnnp-2017-316844","article-title":"Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis","volume":"89","author":"Rizzo","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2022.101771_bib120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-60761-746-4_2","article-title":"A mass spectrometry primer for mass spectrometry imaging","volume":"656","author":"Rubakhin","year":"2010","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib121","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11418-017-1144-z","article-title":"Enzyme-linked immunosorbent assay for the quantitative\/qualitative analysis of plant secondary metabolites","volume":"72","author":"Sakamoto","year":"2018","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.arr.2022.101771_bib122","article-title":"Labeling methods in mass spectrometry based quantitative proteomics","author":"Sap","year":"2012","journal-title":"Integr. Proteom."},{"key":"10.1016\/j.arr.2022.101771_bib123","article-title":"Epidemiology of alpha-synucleinopathies: from Parkinson disease to dementia with Lewy bodies","volume":"Vol. 138","author":"Savica","year":"2016"},{"issue":"D1","key":"10.1016\/j.arr.2022.101771_bib124","doi-asserted-by":"crossref","first-page":"D9","DOI":"10.1093\/nar\/gkz899","article-title":"Database resources of the national center for biotechnology information","volume":"48","author":"Sayers","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.arr.2022.101771_bib125","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0002-9440(10)61113-3","article-title":"Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies","volume":"160","author":"Schlossmacher","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.arr.2022.101771_bib126","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neulet.2009.02.008","article-title":"Reduced CSF CART in dementia with Lewy bodies","volume":"453","author":"Schultz","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.arr.2022.101771_bib127","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5607\/en20042","article-title":"Urinary biomarkers for neurodegenerative diseases","volume":"29","author":"Seol","year":"2020","journal-title":"Exp. Neurobiol."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/bioengineering6010008","article-title":"Characterization of plasma-derived extracellular vesicles isolated by different methods: a comparison study","volume":"6","author":"Serrano-Pertierra","year":"2019","journal-title":"Bioengineering"},{"key":"10.1016\/j.arr.2022.101771_bib129","first-page":"2","article-title":"Excess \u03b1-synuclein worsens disease in mice lacking ubiquitin carboxy-terminal hydrolase L1","author":"Shimshek","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2022.101771_bib130","first-page":"27","article-title":"Methodological challenges associated with meta-analyses in health care and behavioral health research","author":"Shinogle","year":"2012","journal-title":"Biotechnol. Innov. Organ."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib131","first-page":"67","article-title":"Proteomics: a new perspective for cancer","volume":"5","author":"Shruthi","year":"2016","journal-title":"Adv. Biomed. Res."},{"issue":"4","key":"10.1016\/j.arr.2022.101771_bib132","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1192\/bja.2020.28","article-title":"The application of stratified medicine to dementia care","volume":"26","author":"Sidhom","year":"2020","journal-title":"BJPsych Adv."},{"issue":"4","key":"10.1016\/j.arr.2022.101771_bib133","doi-asserted-by":"crossref","first-page":"555","DOI":"10.4103\/ijo.IJO_999_19","article-title":"Use of ocular biomarkers as a potential tool for early diagnosis of Alzheimer\u2019s disease","volume":"68","author":"Singh","year":"2020","journal-title":"Indian J. Ophthalmol."},{"issue":"AUG","key":"10.1016\/j.arr.2022.101771_bib134","first-page":"1","article-title":"MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis","volume":"6","author":"Singhal","year":"2015","journal-title":"Front. Microbiol."},{"issue":"10","key":"10.1016\/j.arr.2022.101771_bib135","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nmeth1097","article-title":"Decoding protein modifications using top-down mass spectrometry","volume":"4","author":"Siuti","year":"2007","journal-title":"Nat. Methods"},{"issue":"30","key":"10.1016\/j.arr.2022.101771_bib136","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1074\/jbc.REV120.011743","article-title":"The emerging role of \u03b1-synuclein truncation in aggregation and disease","volume":"295","author":"Sorrentino","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.arr.2022.101771_bib137","first-page":"151","article-title":"The possible involvement of mitochondrial dysfunctions in lewy body dementia: a systematic review","volume":"30","author":"Spano","year":"2015","journal-title":"Funct. Neurol."},{"issue":"2","key":"10.1016\/j.arr.2022.101771_bib138","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3233\/JAD-2009-0955","article-title":"Cerebrospinal fluid \u03b1-synuclein does not discriminate between dementia disorders","volume":"16","author":"Spies","year":"2009","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2022.101771_bib139","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13195-019-0537-5","article-title":"Amyloid-\u03b2 peptides in cerebrospinal fluid of patients with dementia with Lewy bodies","volume":"11","author":"van Steenoven","year":"2019","journal-title":"Alz Res Therapy"},{"issue":"11","key":"10.1016\/j.arr.2022.101771_bib140","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/mds.111","article-title":"\u03b1-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies","volume":"33","author":"van Steenoven","year":"2018","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib141","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neulet.2004.07.061","article-title":"Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases","volume":"370","author":"Steinacker","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"12","key":"10.1016\/j.arr.2022.101771_bib142","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/brain\/awy265","article-title":"Early microglial activation and peripheral inflammation in dementia with Lewy bodies","volume":"141","author":"Surendranathan","year":"2018","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.arr.2022.101771_bib143","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/gps.4274","article-title":"Serum peptides as candidate biomarkers for dementia with Lewy bodies","volume":"30","author":"Suzuki","year":"2015","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.arr.2022.101771_bib144","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-8993(02)02498-8","article-title":"Tyrosine 125 of \u03b1-synuclein plays a critical role for dimerization following nitrative stress","volume":"938","author":"Takahashi","year":"2002","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.arr.2022.101771_bib145","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.nbd.2010.01.007","article-title":"TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson\u2019s disease and dementia with Lewy bodies","volume":"38","author":"Tanji","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.arr.2022.101771_bib146","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.180138","article-title":"Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: An overview of induced pluripotent stem-cell-based disease models","volume":"8","author":"Taoufik","year":"2018","journal-title":"Open Biol."},{"key":"10.1016\/j.arr.2022.101771_bib147","first-page":"2014","article-title":"The design of a quantitative western blot experiment","author":"Taylor","year":"2014","journal-title":"BioMed. Res. Int."},{"issue":"45","key":"10.1016\/j.arr.2022.101771_bib148","doi-asserted-by":"crossref","first-page":"44405","DOI":"10.1074\/jbc.M308041200","article-title":"Ubiquitination of \u03b1-synuclein in lewy bodies is a pathological event not associated with impairment of proteasome function","volume":"278","author":"Tofaris","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.arr.2022.101771_bib149","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nbt1210-1248","article-title":"Towards a knowledge-based Human Protein Atlas","volume":"28","author":"Uhlen","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.arr.2022.101771_bib150","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1515\/CCLM.2006.258","article-title":"Analytical performance and clinical utility of the INNOTEST\u00ae PHOSPHO-TAU(181P) assay for discrimination between Alzheimer\u2019s disease and dementia with Lewy bodies","volume":"44","author":"Vanderstichele","year":"2006","journal-title":"Clin. Chem. Lab. Med."},{"issue":"4","key":"10.1016\/j.arr.2022.101771_bib151","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1017\/S0033291713000494","article-title":"The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies","volume":"44","author":"Vann Jones","year":"2014","journal-title":"Psychol. Med."},{"issue":"1\u20132","key":"10.1016\/j.arr.2022.101771_bib152","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jns.2007.03.016","article-title":"Diagnostic markers for diagnosing dementia with Lewy bodies: CSF and MIBG cardiac scintigraphy study","volume":"260","author":"Wada-Isoe","year":"2007","journal-title":"J. Neurol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.arr.2022.101771_bib153","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jns.2007.08.018","article-title":"Serum heart-fatty acid binding protein levels in patients with Lewy body disease","volume":"266","author":"Wada-Isoe","year":"2008","journal-title":"J. Neurol. Sci."},{"issue":"18","key":"10.1016\/j.arr.2022.101771_bib154","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/WNL.0b013e3182a9f449","article-title":"\u03b1-Synuclein in cutaneous autonomic nerves","volume":"81","author":"Wang","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib155","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neulet.2007.08.010","article-title":"Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson\u2019s disease","volume":"425","author":"Waragai","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib156","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbrc.2011.07.027","article-title":"Gelsolin co-occurs with Lewy bodies in vivo and accelerates \u03b1-synuclein aggregation in vitro","volume":"412","author":"Welander","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib157","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053250","article-title":"Low CSF levels of both \u03b1-synuclein and the \u03b1-synuclein cleaving enzyme neurosin in patients with synucleinopathy","volume":"8","author":"Wennstr\u00f6m","year":"2013","journal-title":"PLoS One"},{"issue":"June 2020","key":"10.1016\/j.arr.2022.101771_bib158","article-title":"Tissue microarray (TMA) use in post mortem neuropathology","volume":"347","author":"Wilson","year":"2021","journal-title":"J. Neurosci. Methods"},{"issue":"3","key":"10.1016\/j.arr.2022.101771_bib159","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1471-4159.2002.00818.x","article-title":"Highly conserved and disease-specific patterns of carboxyterminally truncated A\u03b2 peptides 1-37\/38\/39 in addition to 1-40\/42 in Alzheimer\u2019s disease and in patients with chronic neuroinflammation","volume":"81","author":"Wiltfang","year":"2002","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.arr.2022.101771_bib160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21062230","article-title":"Fatty acid binding protein 3 enhances the spreading and toxicity of \u03b1-synuclein in mouse brain","volume":"21","author":"Yabuki","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2022.101771_bib161","first-page":"1","article-title":"Recent technical advances in proteomics [ version 1; peer review: 2 approved] Referee Status","volume":"8","author":"Yates","year":"2019","journal-title":"F1000 Res."},{"issue":"3","key":"10.1016\/j.arr.2022.101771_bib162","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.compbiolchem.2007.03.001","article-title":"A new protocol of analyzing isotope-coded affinity tag data from high-resolution LC-MS spectrometry","volume":"31","author":"Yu","year":"2007","journal-title":"Comput. Biol. Chem."},{"issue":"APR","key":"10.1016\/j.arr.2022.101771_bib163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2019.00001","article-title":"The roles of post-translational modifications on \u03b1-synuclein in the pathogenesis of Parkinson\u2019s diseases","volume":"13","author":"Zhang","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2022.101771_bib164","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-biochem-060815-014922","article-title":"Ubiquitin ligases: structure, function, and regulation","volume":"86","author":"Zheng","year":"2017","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"10.1016\/j.arr.2022.101771_bib165","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-0039-1688654","article-title":"Nuclear magnetic resonance spectroscopy for medical and dental applications: a comprehensive review","volume":"13","author":"Zia","year":"2019","journal-title":"Eur. J. Dent."},{"issue":"11","key":"10.1016\/j.arr.2022.101771_bib166","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1021\/ac4001223","article-title":"Orbitrap mass spectrometry","volume":"85","author":"Zubarev","year":"2013","journal-title":"Anal. Chem."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163722002136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163722002136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:08:00Z","timestamp":1761592080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163722002136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":166,"alternative-id":["S1568163722002136"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2022.101771","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From protein biomarkers to proteomics in dementia with Lewy Bodies","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2022.101771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101771"}}